Business Wire09.06.17
Tandem Diabetes Care Inc., a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, has launched the t:lock Connector for its insulin pump cartridges and infusion sets. All of the infusion sets currently offered by the company will be made available with the new t:lock Connector, produced and supplied by Unomedical a/s, a ConvaTec Group plc company.
The t:lock Connector was designed to look and feel like the previous Luer-lock connector, while improving the customer experience of filling an infusion set with insulin. The Connector incorporates a smaller inner cavity, which reduces the amount of insulin used in the process and reduces the time required to fill the infusion set tubing.
“This launch strengthens our overall insulin delivery systems, addressing one of our customers’ most frequent requests to make the infusion set fill process more efficient,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care. “We continue to invest in ways to improve our products and deliver new technology, as part of our overall mission to provide innovative solutions to help improve the lives of people with diabetes.”
“We are excited to further our current partnership with Tandem Diabetes Care with the implementation of their optimized t:lock Connector,” said John M. Lindskog, president of ConvaTec Infusion Devices (Unomedical). “The available t:lock line of infusion sets offers a variety of solutions for their customers, and we look forward to working with Tandem to further expand their offerings in the future.”
Unomedical manufactures Tandem’s existing sets as well as many of the most popular private-labeled infusion sets of major insulin pump manufacturers under their respective brand names. The t:lock versions of Tandem’s current infusion sets will be sold under the brand names AutoSoft, VariSoft and TruSteel. Tandem conducted a gradual rollout of its t:lock Connector to all customers and distributors beginning Sept. 5, and anticipates fully transitioning by the end of 2017.
Tandem Diabetes Care is a medical device company with a user-centric and integrated approach to the design, development, and commercialization of products for people with diabetes who use insulin. The company manufactures and sells the t:slim X2 Insulin Pump, the slimmest and smallest durable insulin pump currently on the market; the t:flex Insulin Pump, the first pump designed for people with greater insulin requirements; and the t:slim G4 Insulin Pump, the first continuous glucose monitoring-enabled pump with touchscreen simplicity. Tandem is based in San Diego, Calif.
The t:lock Connector was designed to look and feel like the previous Luer-lock connector, while improving the customer experience of filling an infusion set with insulin. The Connector incorporates a smaller inner cavity, which reduces the amount of insulin used in the process and reduces the time required to fill the infusion set tubing.
“This launch strengthens our overall insulin delivery systems, addressing one of our customers’ most frequent requests to make the infusion set fill process more efficient,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care. “We continue to invest in ways to improve our products and deliver new technology, as part of our overall mission to provide innovative solutions to help improve the lives of people with diabetes.”
“We are excited to further our current partnership with Tandem Diabetes Care with the implementation of their optimized t:lock Connector,” said John M. Lindskog, president of ConvaTec Infusion Devices (Unomedical). “The available t:lock line of infusion sets offers a variety of solutions for their customers, and we look forward to working with Tandem to further expand their offerings in the future.”
Unomedical manufactures Tandem’s existing sets as well as many of the most popular private-labeled infusion sets of major insulin pump manufacturers under their respective brand names. The t:lock versions of Tandem’s current infusion sets will be sold under the brand names AutoSoft, VariSoft and TruSteel. Tandem conducted a gradual rollout of its t:lock Connector to all customers and distributors beginning Sept. 5, and anticipates fully transitioning by the end of 2017.
Tandem Diabetes Care is a medical device company with a user-centric and integrated approach to the design, development, and commercialization of products for people with diabetes who use insulin. The company manufactures and sells the t:slim X2 Insulin Pump, the slimmest and smallest durable insulin pump currently on the market; the t:flex Insulin Pump, the first pump designed for people with greater insulin requirements; and the t:slim G4 Insulin Pump, the first continuous glucose monitoring-enabled pump with touchscreen simplicity. Tandem is based in San Diego, Calif.